Quantum Computing Raises $348M, Ramps TFLN Chip Build as R&D Burns and Revenue Lags

Quantum Computing Inc. (OTCBB: QUBT)

Quick summary - what's happening inside the company
- The company completed large equity raises in H1 2025 (Jan and June placements) and now holds a big cash cushion to fund R&D and buildout of its TFLN chip facility in Tempe.
- Management is aggressively scaling R&D and go-to-market resources (headcount, lab equipment, lease expansions).
- Revenue remains negligible and volatile (services / proofs-of-concept), while losses are driven by operating spend and mark‑to‑market swings from QPhoton-related warrants.
- Litigation remains active (class action, multiple derivative suits) but the BV Advisory disputes were settled on July 17, 2025 via payment and issuance of shares.

Key facts & statistics (as presented in the 10‑Q; amounts are in thousands unless noted)
- Cash and cash equivalents: $348,758 (June 30, 2025) - up from $78,945 (Dec 31, 2024).
- Total assets: $426,084 (June 30, 2025) vs $153,559 (Dec 31, 2024).
- Working capital: $346,253 (June 30, 2025).
- Total revenue: $61 (three months ended 6/30/25); $100 (six months ended 6/30/25).
- Cost of revenue: $35 (Q2 2025); Gross profit: $26 (Q2 2025); Gross margin Q2 2025 = 43%.
- Research & development expense: $5,975 (Q2 2025); $8,960 (six months 2025).
- Total operating expenses Q2 2025: $10,197; Loss from operations Q2 2025: (10,171).
- Mark-to-market change in fair value of derivative liability: (28,096) (Q2 2025); (4,466) (six months 2025).
- Net loss: (36,482) (Q2 2025); (19,500) (six months 2025).
- Loss per share (basic) Q2 2025: $(0.26); six months 2025: $(0.14).
- Derivative liability (QPhoton warrants) carrying value: $24,594 (June 30, 2025) - down from $40,532 (Dec 31, 2024).
- Additional paid‑in capital: $615,948; Accumulated deficit: (219,982).
- Shares issued/outs. on balance sheet: 157,911 (as of June 30, 2025) - filing notes amounts in thousands; separate filing line shows 159,883,187 shares outstanding as of August 13, 2025.
- Cash provided by financing activities, six months 2025: $283,104 (net proceeds from equity issuances).
- Management disclosure: disclosure controls and procedures were concluded NOT effective as of June 30, 2025.

Income statement - positives
- Gross profit is positive (Q2 gross profit $26) and gross margin improved to 43% in Q2 2025 vs 32% prior year - indicates favorable contract/labor mix on the small revenue base.
- Interest and other income rose to $1,843 in Q2 (and $3,539 for six months) driven by higher cash balances earning interest - a non‑operating offset while cash remains large.
- Strong balance-sheet liquidity after equity raises: cash and working capital now support near-term spending plans (management says cash suffices for at least the next 12 months).

Income statement - negatives
- Revenue is tiny and declining YoY: Q2 2025 revenue $61 vs $183 in Q2 2024 (‑67%). The business is still development‑stage with minimal product sales.
- Operating expenses ballooned: R&D up 185% YoY in Q2 (to $5,975) and total operating expenses increased 91% in Q2 - burn increasing as company scales.
- Large non‑cash, volatile losses from warrant liability re‑measurements: a $28.1M mark‑to‑market loss in Q2 drove the large net loss; future stock moves could produce additional significant swings.
- Accumulated deficit remains large: (219,982).
- Significant dilution risk from recent and outstanding equity, options and warrants - weighted average shares rose materially vs prior periods.
- Controls weakness: company reported disclosure controls were not effective as of quarter‑end - governance / reporting risk.

What to watch next (straightforward)
- Revenue traction: signs of repeatable product sales or subscription revenue beyond R&D contracts.
- R&D milestones and commercialization of TFLN chip facility (AZ Chips Facility) - progress de‑risks the narrative.
- Warrant/derivative exposure: stock price moves will continue to create volatile earnings swings until instrument settlement/exercise risk reduces.
- Use of cash vs. additional financings: despite large cash, continued high burn may require more capital later; dilution is likely if more equity is needed.
- Litigation and governance: outcomes of the securities class action and derivative suits and remediation of disclosure controls.

Bottom line: QCi has substantially improved its liquidity via big equity raises and is rapidly investing in R&D and a TFLN manufacturing footprint. However, revenue is still negligible, operating spend is growing fast, and earnings are highly volatile because of QPhoton‑warrant mark‑to‑market swings and outstanding dilution - monitor commercialization progress, cash burn, and the warrant liability closely.